Several radiolabeled FAP inhibitors (FAPI) targeting FAP expression in CAFs and characterized by rapid renal clearance and high tumor-to-background uptake ratio (TBR) have been developed to allow early cancer detection through PET imaging [9]. This evidence concerns the gene FAP and cancer.